A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Kutlu, Ömer; Metin, Ahmet

Kutlu, Ömer; Metin, Ahmet.

Kutlu Ö; Department of Dermatology and Venereology, School of Medicine, Usak University, Usak, Turkey.
Metin A; Department of Dermatology and Venereology, School of Medicine, Usak University, Usak, Turkey.

Dermatol Ther ; 33(4): e13383, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-38637

Subject(s)

Coronavirus Infections/drug therapy; Hydroxychloroquine/administration & dosage; Oseltamivir/administration & dosage; Pneumonia, Viral/drug therapy; Psoriasis/etiology; Aged; Antiviral Agents/administration & dosage; Antiviral Agents/adverse effects; COVID-19; Female; Humans; Hydroxychloroquine/adverse effects; Oseltamivir/adverse effects; Pandemics; Psoriasis/pathology; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Psoriasis / Coronavirus Infections / Oseltamivir / Hydroxychloroquine Type of study: Case report Limits: Aged / Female / Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13383

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google